These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 16927820)

  • 1. [Application of high-throughput technologies in pharmaceutics].
    Bai XL; Gao YL
    Yao Xue Xue Bao; 2006 Jun; 41(6):487-92. PubMed ID: 16927820
    [No Abstract]   [Full Text] [Related]  

  • 2. High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids.
    Morissette SL; Almarsson O; Peterson ML; Remenar JF; Read MJ; Lemmo AV; Ellis S; Cima MJ; Gardner CR
    Adv Drug Deliv Rev; 2004 Feb; 56(3):275-300. PubMed ID: 14962582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New QSPR study for the prediction of aqueous solubility of drug-like compounds.
    Duchowicz PR; Talevi A; Bruno-Blanch LE; Castro EA
    Bioorg Med Chem; 2008 Sep; 16(17):7944-55. PubMed ID: 18701302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Future perspectives in pharmaceutics: contributions from younger scientists. Preface.
    Siepmann J
    Int J Pharm; 2008 Dec; 364(2):157-8. PubMed ID: 18929633
    [No Abstract]   [Full Text] [Related]  

  • 5. Solid form screening--a review.
    Aaltonen J; Allesø M; Mirza S; Koradia V; Gordon KC; Rantanen J
    Eur J Pharm Biopharm; 2009 Jan; 71(1):23-37. PubMed ID: 18715549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Application of supercritical solution rapid expansion technology in preparation of fine pharmacal particles].
    Zhang ZY; Li HL; Lei ZJ
    Zhongguo Zhong Yao Za Zhi; 2006 Dec; 31(23):1933-6. PubMed ID: 17348181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theme issue "Solid state and solid dosage forms".
    Kleinebudde P
    Eur J Pharm Biopharm; 2009 Jan; 71(1):1. PubMed ID: 18817869
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessing drug-likeness--what are we missing?
    Vistoli G; Pedretti A; Testa B
    Drug Discov Today; 2008 Apr; 13(7-8):285-94. PubMed ID: 18405840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Achieving polymorph selectivity in the crystallization of pharmaceutical solids: basic considerations and recent advances.
    Reutzel-Edens SM
    Curr Opin Drug Discov Devel; 2006 Nov; 9(6):806-15. PubMed ID: 17117688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing early formulations: practice and perspective.
    Li P; Zhao L
    Int J Pharm; 2007 Aug; 341(1-2):1-19. PubMed ID: 17658228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of in silico models for estimating drug preformulation risk in PEG400/water and Tween80/water systems.
    Crivori P; Morelli A; Pezzetta D; Rocchetti M; Poggesi I
    Eur J Pharm Sci; 2007 Nov; 32(3):169-81. PubMed ID: 17714921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Approaches for the development of solid and semi-solid lipid-based formulations.
    Jannin V; Musakhanian J; Marchaud D
    Adv Drug Deliv Rev; 2008 Mar; 60(6):734-46. PubMed ID: 18045728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Amorphization in pharmaceutical technology].
    Révész P; Laczkovich O; Eros I
    Acta Pharm Hung; 2004; 74(1):39-44. PubMed ID: 15524047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biopartitioning micellar chromatography: its application in evaluating drug membrane transport and activity].
    Mao JJ; Sun J; He ZG
    Yao Xue Xue Bao; 2005 Oct; 40(10):865-70. PubMed ID: 16408799
    [No Abstract]   [Full Text] [Related]  

  • 15. [A review of pharmaceutics in the 1980's and its prospect].
    Huang SY
    Yao Xue Xue Bao; 1991; 26(3):234-40. PubMed ID: 1957667
    [No Abstract]   [Full Text] [Related]  

  • 16. Polymorph control: past, present and future.
    Llinàs A; Goodman JM
    Drug Discov Today; 2008 Mar; 13(5-6):198-210. PubMed ID: 18342795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of molecular interactions in solid dosage forms; challenge to molecular pharmaceutics.
    Yamamoto K; Limwikrant W; Moribe K
    Chem Pharm Bull (Tokyo); 2011; 59(2):147-54. PubMed ID: 21297291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absorption-excipient-pH classification gradient maps: sparingly soluble drugs and the pH partition hypothesis.
    Avdeef A; Kansy M; Bendels S; Tsinman K
    Eur J Pharm Sci; 2008 Jan; 33(1):29-41. PubMed ID: 17983735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supercritical fluid technologies: an innovative approach for manipulating the solid-state of pharmaceuticals.
    Pasquali I; Bettini R; Giordano F
    Adv Drug Deliv Rev; 2008 Feb; 60(3):399-410. PubMed ID: 17964684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The importance of micronization in the design of dosage forms I. Theoretical and biopharmaceutical aspects].
    Antal I
    Acta Pharm Hung; 2006; 76(2):95-103. PubMed ID: 17094668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.